Articles tagged with Viral Infections
Research at DDW 2011 presents innovative detection practices to increase liver disease detection rates and prevent premature death. Vaccination rates against hepatitis A and B in patients with chronic liver disease are low, highlighting the need for increased vaccination efforts.
A new study found that cattle infected with foot-and-mouth disease are only contagious for 1.7 days, sparking hope for reduced culling and improved testing methods. Researchers recommend developing pre-clinical diagnostic tools to detect infected animals before symptoms appear, allowing for more targeted interventions.
Scientists have identified a single amino acid change in the chikungunya virus' exterior protein that enables it to infect Aedes albopictus mosquitoes, allowing for rapid spread across India and Southeast Asia. The discovery sheds light on why outbreaks occurred despite previous strains being present in the region.
Researchers found that current prevention and screening standards are worth the cost and may need expansion to include more of the population. Screening followed by treatment with a low-cost, high-resistance nucleoside or nucleotide is cost-effective at $29,000 per quality-adjusted life year gained.
A team of researchers identified TIM-1 as the cellular protein that acts as a receptor for Ebola and Marburg viruses. An antibody targeting TIM-1 blocks infection by both viruses, potentially providing a way to prevent initial infection and limit outbreak spread.
Researchers Peter Cummings and Michael Simpson propose that mimicking natural processes can lead to more efficient and reliable devices. By exploiting contrarian behavior and 'noise,' scientists can develop technology that outperforms traditional methods, as seen in the humble bacterial cell's ability to withstand modern medicines.
A new study analyzed mutations of the 2009 pandemic influenza A(H1N1) virus in Japan, identifying unique triple combination of bird, swine, and human flu viruses. The research revealed rapid mutation of virus strains with an extremely high evolutionary rate, paving the way for the development of new diagnostic kits.
Researchers tested an intervention targeting multiple health-related behaviors in African American couples where one partner is HIV-positive. The study found that the intervention led to increased fruit and vegetable consumption, physical activity, and cancer screenings among participants.
Researchers found that pulmonary administration of granulocyte macrophage-colony stimulating factor (GM-CSF) significantly reduces flu symptoms and prevents death in mice infected with lethal doses of influenza virus. The study suggests a novel method to confer marked resistance to influenza by enhancing innate immune mechanisms.
A new study on deer mice on California's Channel Islands has found that precipitation, predator diversity, and island characteristics are key factors in regulating the spread of hantavirus. The research suggests that a stronger relationship between climate change and human health risk may exist than previously thought.
Researchers have identified two bioflavonoids, catechin and naringenin, with antiviral activity against hepatitis C virus. These compounds, combined with existing flavonoid quercetin, may provide a promising therapy for millions of people worldwide.
Researchers have found that flu virus infection is necessary for pneumococcal bacteria to efficiently spread between individuals. The study has implications for managing influenza pandemics and reducing pneumococcal infections in young children, who are highly susceptible.
Cytotoxic T cells (CTLs) get a head start on viral replication by dividing early during their journey to infected tissue. This allows them to quickly respond to the virus upon arrival, making them more effective in defending against infection.
A Phase II dose-ranging study of BMS-790052 plus PEG-interferon alfa and ribavirin showed higher rates of sustained virologic response compared to PEG-interferon alfa and ribavirin alone. The regimen achieved up to 92% SVR12 in treatment-naïve patients with hepatitis C genotype 1.
Researchers have successfully infected and replicated swine hepatitis E virus in human hepatocytes, confirming its zoonotic potential. This breakthrough verifies the infectious disease can be transmitted from animals to humans., Hepatitis E is a major cause of epidemic and acute sporadic hepatitis worldwide.
Clinical trials confirm efficacy and safety of new protease inhibitors in combination with PegIFN-alpha and ribavirin for HCV patients who have previously failed therapy. The treatments demonstrated good response rates at key timepoints and remarkably high sustained viral response rates.
A two-year trial found that switching from entecavir to lamivudine resulted in a 24% virologic rebound rate and 12% drug-resistance rate. Patients who continued on entecavir therapy maintained undetectable HBV DNA levels.
New data reveals novel lymphocyte-hepatocyte interactions regulated by HCV, affecting CD4+ T-cell trafficking and cytokine expression. This understanding may influence anti-viral immune responses and chronic HCV replication.
Researchers at Dana-Farber Cancer Institute have identified a promising target for an AIDS vaccine: the V3 loop of the virus's protein envelope. Immune system antibodies aimed at this loop may offer protection against multiple genetic subtypes of HIV-1, offering hope for a universally effective vaccine.
A new three-drug cocktail has been shown to eliminate the hepatitis C virus in patients more effectively than the current two-drug regimen, with significantly higher rates of sustained virologic response. This breakthrough treatment offers new hope for patients who have not responded to previous therapy.
A new study finds that a human respiratory virus has killed two mountain gorillas in Rwanda, confirming the risk of disease transmission between humans and animals. The virus, human metapneumovirus (HMPV), was detected in both gorillas, highlighting the need for increased conservation efforts to protect these endangered animals.
A new Johns Hopkins study shows that each strain of the cat-borne parasite Toxoplasma gondii triggers a unique reaction in human nerve cells, varying the severity of infection. The research found alterations triggered by the most virulent strain to be linked to brain development and central nervous system function.
Researchers identify resistance to cucurbit yellow stunting disorder virus (CYSDV) in exotic melon varieties, with potential applications for the southwestern United States. Whitefly populations and high temperatures exacerbate CYSDV infection, highlighting the need for integrated management strategies.
A cohort study found that hepatitis B virus (HBV) infection decreases the percentage of metastases in colorectal cancer patients, while increasing extrahepatic metastases. This suggests HBV may serve as a prognostic factor for hepatic metastasis formation in CRC patients.
Researchers at the University of Edinburgh have discovered a direct link between cholesterol levels and the immune system's response to viral infections. By lowering cholesterol, the body can starve viruses of the nutrients they need to grow, potentially enhancing the immune system's ability to fight off infections.
Researchers discovered a critical link between respiratory syncytial virus and oxidative stress, which causes lung inflammation and damage in children. The study found that the virus blocks the activity of Nrf2, a protein needed for antioxidant enzymes, leading to increased reactive oxygen species and cell killing.
Researchers have identified a small virus that targets and rescues infected zooplankton from death. The discovery sheds light on the evolutionary origin of jumping genes found in other organisms.
Researchers discovered that DMXAA enhances flu vaccine efficacy by causing the body to produce its own antiviral proteins. The drug may also treat newly emerging flu strains and possibly other viruses, offering a potential lifesaving therapy for millions.
Researchers found no evidence of viral infection causing acute exacerbation of idiopathic pulmonary fibrosis (IPF) in most patients. Instead, torque teno virus (TTV) was detected in lung fluid samples from a small percentage of IPF patients, suggesting it may be a marker of lung injury rather than a cause.
A recent study found that hepatitis C patients in the US are twice as likely to be uninsured, with only a third having access to antiviral therapy. The lack of adequate health insurance coverage is a significant barrier to treatment, particularly for those with comorbidities.
A cancer-causing retrovirus exploits key proteins in host cells to extend cell life and spread. The study found that the viral protein targets ATM and REG-gamma, leading to prolonged cell survival and increased virus transmission.
New research shows reovirus-infected cancer cells release pro-inflammatory proteins that recruit and activate white blood cells, killing cancer. A cellular signalling protein, Ras, is abnormally activated in many cancers, providing a window of opportunity for reovirus infection.
The Dengue Vaccine Initiative aims to accelerate the development and utilization of safe, affordable, and broadly protective vaccines to combat dengue fever. The initiative will generate data on the burden of disease, potential private demand, cost of illness, and seroprevalence in several countries.
Researchers found that a viral infection in a parasite can trigger severe responses in immune cells, increasing disease severity. The study suggests that antiviral strategies could be used to reduce damage caused by Leishmania strains carrying viruses.
The economic burden of dengue fever in the Western Hemisphere surpasses other viral illnesses, with estimated annual costs of $2.1 billion. Direct and indirect costs include ambulatory care, hospitalization, productivity losses, and government expenditures.
Researchers at the University of Southampton successfully crystallized a key norovirus enzyme, paving the way for the development of an antiviral treatment. The breakthrough could help alleviate the significant public health burden caused by noroviruses, which are responsible for one million cases in the UK each year.
A study by Virginia Tech researchers found that airborne influenza A viruses can remain suspended in the air for hours and are associated with fine particles less than 2.5 micrometers. The average concentration of viruses was 16,000 per cubic meter of air, which is sufficient to induce infection.
The European Diabetes Research Network, funded by the EU, will investigate the possible role of virus infection in causing type 1 diabetes. The network aims to develop a vaccine to prevent diabetes in children and improve diagnosis and patient care.
A study published in the World Journal of Gastroenterology investigated the seroprevalence of Hepatitis A virus (HAV) antibodies among patients with chronic viral liver disease in South Korea. The study found that most patients above 40 years old have already been exposed to HAV, highlighting the need for vaccination against HAV.
Researchers discover naturally occurring viral infections in C. elegans, a millimeter-long worm used extensively for decades to study many aspects of biology. The findings provide insights into the way viruses and their hosts interact, shedding light on fundamental phenomena such as RNA interference and cell self-destruction.
Researchers found that the nematode C. elegans, a millimeter-long worm used extensively for decades to study biology, gets naturally occurring viral infections. The discovery means C. elegans is likely to help scientists study the way viruses and their hosts interact.
Scientists identified a viral infection that causes high mortality among soft-shell crabs, which can result in significant financial losses for Chesapeake Bay watermen. By developing a genome-based technique to detect the virus, researchers aim to help improve the soft shell harvest and bring more profitable products to market.
A new company, Fixed Phage Limited, has been launched to commercialize technology developed at the University of Strathclyde to tackle bacterial infections and contamination. The technology uses bacteriophages, naturally occurring viruses that are non-toxic but effective against bacteria.
Researchers at the University of Illinois Chicago have discovered a family of small molecules that bind to the Ebola virus's outer protein coat and inhibit its entry into human cells. The findings demonstrate a potential breakthrough in preventing Ebola infection, with further studies planned to confirm efficacy.
A study published in Clinical Infectious Diseases suggests that convalescent plasma therapy may reduce the death rate in patients severely ill with 2009 H1N1 influenza. The treatment showed a 20% mortality rate compared to 55% in non-treated patients, and reduced viral load at a higher rate.
Researchers found that recent bus or tram use within five days of symptom onset was associated with a six-fold increased risk of going to the doctor. Daily users may be protected against seasonal influenza and pandemic risks due to repeated exposure, experts say.
A recent study published in the Journal of Biological Chemistry has shed light on how human papillomavirus (HPV) proteins evade the human immune system. The research reveals that HPV's E6 protein can latch onto and inhibit human protein SAP97, preventing its normal function.
Scientists have identified a protein biomarker that predicts the efficacy of hepatitis C treatment, enabling improved patient management. The discovery of IP-10 as a prognostic biomarker could lead to the development of a diagnostic test to distinguish between effective and ineffective treatments.
A new study published in Retrovirology reveals that cell samples used in previous research were contaminated with XMRV, not the cause of chronic fatigue syndrome. The researchers developed improved methods to detect XMRV and rule out infection by this virus as a cause of the disease.
Researchers have identified a novel type of papillomavirus, EcPV-2, linked to equine genital cancer. The virus is closely related to human genital cancers and its presence in affected horses suggests a potential cause and cure.
Researchers discovered the FMD virus selectively infects epithelial cells in the nasopharynx after just six hours of exposure. This breakthrough could lead to the development of more effective vaccines and potentially eradicate the disease, which causes significant economic losses globally.
A new study suggests that influenza virus infection in young mice protected against the development of allergic asthma. The study also found that a compound isolated from Helicobacter pylori activated a subset of natural killer T cells, which may prevent asthma.
Researchers at Johns Hopkins Medicine have discovered a new regulatory protein, GAKIN, that oversees the activity of CARD11, a key player in immune cell activation. This finding presents opportunities to develop new treatments for autoimmune diseases and cancer by targeting hyperactive immune cells.
A recent study published in Nature found a correlation between biodiversity loss and increased incidence of infectious diseases. Researchers discovered that environmental degradation can lead to an increase in disease-carrying pathogens, as seen in the decline of opossum populations, which allows ticks to flourish and spread Lyme disease.
Researchers at the University of Gothenburg have discovered that superantigens, produced by staphylococcus bacteria, can activate the immune system in more ways than previously thought. This complex interaction may be behind several illnesses, including long-term wound infections and autoimmune disorders.
Researchers have identified a genetic basis for broad-spectrum resistance to the Turnip mosaic virus, which affects key brassica crops. The team's breakthrough could lead to the development of commercial varieties with improved resistance, boosting UK crop yields and food security.
The structure of Lassa virus protein reveals how it evades the host's immune system and hijacks infected cells' machinery. Scientists discovered a unique mechanism called cap-stealing, where the virus steals the host cell's RNA cap to suppress interferon production.
A team of researchers identified the gene Trib1 in mice, which regulates lipid production by the liver. Overexpression of Trib1 decreased blood lipids, while lack of Trib1 increased them. This suggests that TRIB1 is responsible for associations between chromosome 8 and lipid levels.
Researchers at UNC identify cellular communicators for cancer virus, revealing a new mechanism by which the Epstein-Barr virus manipulates cells and induces uncontrolled growth. The study shows that infected cells can produce altered exosomes that enter recipient cells, changing their growth patterns.
Researchers at the University of Illinois have discovered a new virus in switchgrass that can cause mosaic and yellow streak symptoms, reducing photosynthesis and biomass yield. The virus, Marafivirus, is related to Maize rayado fino virus and has the potential to affect other crops.